(December 5, 2017, 2:46 PM EST) -- MUNTINLUPA, Philippines — The Philippines Food and Drug Administration on Dec. 4 ordered Sanofi Pasteur Inc. to suspend the sale and distribution of its Dengvaxia dengue fever vaccine in the wake of a post-marketing clinical study indicating that the vaccine poses a potential risk to patients who have not previously been infected by the virus....